+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Transgenic expression of human kallikrein prevents altered left ventricular function, the decline in sarcoplasmic reticulum calcium pump activity and the rise in cardiac collagen content in diabetic rats



Transgenic expression of human kallikrein prevents altered left ventricular function, the decline in sarcoplasmic reticulum calcium pump activity and the rise in cardiac collagen content in diabetic rats



Circulation 102(18 Suppl.): II 267




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 035974126

Download citation: RISBibTeXText


Related references

Transgenic expression of human kallikrein prevents haemodynamic alterations and decline in sarcoplasmic reticulum calcium pump activity in diabetic rats. European Heart Journal 21(Abstract Suppl.): 3, August-September, 2000

Transgenic expression of human kallikrein prevents sarcoplasmic reticular calcium ion transport dysfunction in diabetic rat heart. Hypertension 36(4): 655, 2000

Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene. Faseb Journal 18(7): 828-835, 2004

Reverse mode of the sarcoplasmic reticulum calcium pump and load-dependent cytosolic calcium decline in voltage-clamped cardiac ventricular myocytes. Biophysical Journal 78(1): 322-333, 2000

Transgenic expression of kallikrein prevents left ventricular dysfunction and inhibits endothelial induction of ICAM-1 and intramyocardial LFA-1/Mac-1+ infiltration in streptozotocin-induced diabetic cardiopathy in rats. Circulation 104(17 Suppl.): II 198, 2001

Improvement of defective sarcoplasmic reticulum Ca2+ transport in diabetic heart of transgenic rats expressing the human kallikrein-1 gene. Faseb Journal 18(15): 1967-1969, 2004

Transgenic activation of the kallikrein-kinin system prevents streptozotocin-diabetic hearts from cardiac fibrosis and left ventricular dysfunction. European Heart Journal 22(Abstract Suppl.): 54, 2001

Prevention of sarcoplasmic reticular Ca transport dysfunction in diabetic heart with transgenic human kallikrein expression is not due to altered SERCA2 and phospholamban expression. Naunyn-Schmiedeberg's Archives of Pharmacology 362(4-5 Suppl.): R29, 2000

Interaction of calcium and magnesium on calcium ATPase activity is altered in cardiac sarcoplasmic reticulum isolated from old rats. FASEB Journal 7(3-4): A817, 1993

Diastolic contractile dysfunction and altered sarcoplasmic reticulum gene expression in cardiac hypertrophy of renin transgenic rats. European Heart Journal 16(ABSTR Suppl. ): 101, 1995

Cardiac sarcoplasmic reticulum calcium transport activity of thyroidectomized rats: the role of endogenous myocardial acylcarnitines and calcium pump protein. Pharmacology 46(3): 130-141, 1993

Cardiac Sarcoplasmic Reticulum Calcium Transport Activity of Thyroidectomized Rats: The Role of Endogenous Myocardial Acylcarnitines and Calcium Pump Protein. Pharmacology 46(3): 130-141, 1993

Altered sarcoplasmic reticulum gene expression in cardiac hypertrophy of renin transgenic rats corresponds to diastolic contractile dysfunction. Circulation 92(8 Suppl. ): I348-I349, 1995

Decrease in sarcoplasmic reticulum calcium content, not myofilament function, contributes to muscle twitch force decline in isolated cardiac trabeculae. Journal of Muscle Research and Cell Motility 35(3-4): 225-234, 2015

Calcium uptake activity of cardiac sarcoplasmic reticulum in myo-inositol-treated diabetic rats. General Pharmacology 21(2): 251-254, 1990